Acquisitions

Acquisition of US-based Fortress Medical Systems accelerates BID Equity‘s life science software group around German XClinical and French Carenity

EvidentIQ, 04 Feb 2021

BID Equity Fund II, a fund advised by BID Equity, acquires Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system.

The recent transaction which followed shortly on the acquisition of the French analytics platform Carenity, enables BID Equity’s life science platform around German XClinical and French Carenity to expand its footprint in the US market and gain new customer segments in the medical device manufacturer and pharmaceutical segments.

Fortress Medical Systems was founded in 1997. Their flagship product Clindex® is known as one of the first integrated software systems designed for clinical trials.

Previous

BID Equity Fund II acquires analytics platform Carenity forging a new life science group with XClinical

Next

Acquisition of Patronis and TTS: BID Equity-backed myneva group expands its footprint in Austria and in the Netherlands

More EvidentIQ news

25 Jan 2021

BID Equity Fund II, a fund advised by BID Equity, acquires France-based Carenity, an anlytics platform supporting +500,000 patients and caregivers worldwide.

12 Sep 2019

BID Equity Fund II, a fund advised by BID Equity, acquires a majority stake in XClinical GmbH. XClinical is a leading international provider of software solutions for drug and medical device studies.